Initial experience with EUS-guided microbiopsy forceps in diagnosing pancreatic cystic lesions: A multicenter

Bojan Kovacevic1, John Gásdal Karstensen2, Roald Flesland Havre3

  • 1Division of Endoscopy, Gastro Unit, Copenhagen University Hospital Herlev, Copenhagen, Denmark.

Endoscopic Ultrasound
|September 1, 2018
PubMed
Abstract

Insights

A novel microbiopsy forceps for endoscopic ultrasound (EUS)-guided pancreatic cyst evaluation shows promising feasibility. This tool achieved good technical and clinical success rates in a multicenter study.

Area of Science:

  • Gastroenterology
  • Endoscopic Ultrasound (EUS)
  • Pancreatic Pathology

Background:

  • Pancreatic cystic lesions pose diagnostic challenges.
  • Endoscopic ultrasound (EUS) is crucial for evaluating pancreatic cysts.
  • Histological analysis is key for accurate diagnosis.

Purpose of the Study:

  • To evaluate the utility of a novel through-the-needle microbiopsy forceps for EUS-guided pancreatic cyst wall sampling.
  • To assess the feasibility and performance of this new instrument in a multicenter setting.

Main Methods:

  • Retrospective analysis of patients undergoing EUS-guided microbiopsy for pancreatic cysts across six international centers.
  • Data collected included patient demographics, EUS findings, technical/clinical success rates, and histopathological results.

Main Results:

  • Technical success rate of 85.7% (24/28 patients).
  • Histopathological specimens were of good quality, aiding diagnosis in 71.4% (20/28 patients).
  • An acceptable safety profile with 10.7% (3/28) adverse events.

Conclusions:

  • The novel microbiopsy forceps demonstrates feasibility for EUS-guided pancreatic cyst diagnosis.
  • Acceptable technical and clinical success rates were observed in this multicenter study.
  • Further prospective research is needed to compare its diagnostic efficacy against existing methods.

Related Concept Videos

Initiation of Translation02:33

Initiation of Translation

Initiating translation is complex because it involves multiple molecules. Initiator tRNA, ribosomal subunits, and eukaryotic initiation factors (eIFs) are all required to assemble on the initiation codon of mRNA. This process consists of several steps that are mediated by different eIFs.
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
39.0K
Initiation of Translation02:33

Initiation of Translation

8.1K
Diagnosing Acidosis and Alkalosis01:24

Diagnosing Acidosis and Alkalosis

Diagnosing acid-base imbalances involves systematically analyzing arterial blood samples, focusing on three key measurements: pH, bicarbonate (HCO3−) concentration, and carbon dioxide partial pressure (PCO2). This analysis follows a four-step process that helps identify the imbalance's underlying cause and nature.
First, the pH level is assessed to determine whether the blood pH is normal (7.35–7.45), low (acidosis), or high (alkalosis).
Next, the PCO2  and...
1.2K
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
886
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
543
Transcription Initiation01:47

Transcription Initiation

Initiation is the first step of transcription in eukaryotes. Prokaryotic RNA Polymerase (RNAP) can bind to the template DNA and start transcribing. On the other hand, transcription in eukaryotes requires additional proteins, called transcription factors, to first bind to the promoter region in the DNA template. This binding helps recruit the specific RNAP that can assemble on the DNA and start transcription.
The promoters and enhancers and their accessory proteins allow tight regulation of...
21.2K